Skip to main content

Peer Review reports

From: A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years

Original Submission
21 Nov 2019 Submitted Original manuscript
11 Mar 2020 Author responded Author comments - Charissa Fay Corazon Borja-Tabora
14 Feb 2020 Reviewed Reviewer Report - Gaston De Serres
19 Feb 2020 Reviewed Reviewer Report - Merryn Voysey
Resubmission - Version 2
11 Mar 2020 Submitted Manuscript version 2
15 May 2020 Author responded Author comments - Charissa Fay Corazon Borja-Tabora
13 Apr 2020 Reviewed Reviewer Report - Merryn Voysey
Resubmission - Version 3
15 May 2020 Submitted Manuscript version 3
Publishing
18 May 2020 Editorially accepted
18 Jun 2020 Article published 10.1186/s12879-020-05104-5

You can find further information about peer review here.

Back to article page